Table 4.
Gene variant | Variant vs. reference genotype comparison | European-Americans |
African-Americans |
||
---|---|---|---|---|---|
HF | Moderate and severe HF | HF | Moderate and severe HF | ||
COMT Val158Met | +/+, +/− vs. −/− | 0.71 (0.31–1.60) | 1.21 (0.48–3.04) | 1.30 (0.59–2.88) | 1.44 (0.67–3.09) |
+/− vs. −/− | 0.63 (0.23–1.69) | 1.17 (0.45–3.09) | 0.97 (0.42–2.23) | 1.03 (0.45–2.37) | |
+/+ vs. −/− | 0.75 (0.32–1.79) | 1.30 (0.44–3.84) | 6.67 (0.80–55.67) | 4.20 (1.13–15.59)a | |
CYP3A4*1B | +/+, +/− vs. −/− | 1.33 (0.38–4.70) | 0.68 (0.16–2.86) | 1.10 (0.39–3.13) | 1.09 (0.39–3.04) |
+/− vs. −/− | 1.06 (0.28–4.0) | 0.42 (0.08–2.21) | 1.31 (0.42–4.06) | 1.03 (0.39–3.53) | |
+/+ vs. −/− | b | b | 0.91 (0.29–2.82) | 1.17 (0.39–3.53) | |
CYP1A2*1F | +/+, +/− vs. −/− | 0.96 (0.32–2.88) | 1.60 (0.41–6.18) | 1.00 (0.32–3.10) | 1.69 (0.53–5.43) |
+/− vs. −/− | 1.47 (0.45–4.85) | 1.72 (0.42–7.13) | 1.31 (0.39–4.39) | 1.91 (0.56–6.58) | |
+/+ vs. −/− | 0.77 (0.24–2.42) | 1.50 (0.37–6.07) | 0.77 (0.23–2.56) | 1.49 (0.43–5.16) | |
CYP1B1*3 | +/+, +/− vs. −/− | 1.18 (0.58–2.42) | 0.88 (0.41–1.91) | 2.24 (0.49–10.24) | 6.57 (0.73–58.82) |
+/− vs. −/− | 1.18 (0.56–2.51) | 0.82 (0.36–1.86) | 1.38 (0.61–13.89) | 5.34 (0.80–51.40) | |
+/+ vs. −/− | 1.18 (0.42–3.30) | 1.10 (0.37–3.31) | 2.92 (0.61–13.89) | 7.25 (0.79–65.89) | |
CYP1B1*4 | +/+, +/− vs. −/− | 1.39 (0.66–2.92) | 0.77 (0.35–1.79) | 0.11 (0.02–0.48)c | 0.51 (0.79–65.89) |
+/− vs. −/− | 1.38 (0.64–2.94) | 0.82 (0.36–1.88) | 0.11 (0.02–0.48) | 0.51 (0.79–65.89) | |
+/+ vs. −/− | 1.70 (0.09–33.51) | b | b | b |
Odds ratios adjusted for age, BMI, alcohol consumption, and menopausal stage.
P = 0.03.
Estimate uninterpretable due to insufficient data.
P = 0.003.